TL;DR
- •Excessive yawning is a well-documented SSRI/SNRI side effect with a published prevalence around 5-15% in clinical case series and pharmacovigilance data, though it's under-reported in standard adverse-event registers.
- •The mechanism: SSRIs increase serotonin in hypothalamic and brainstem yawning-control pathways, producing yawning that's unrelated to fatigue or boredom.
- •Patients describe yawning every few minutes throughout the day, often in social or work situations where it's disruptive or embarrassing. Yawns may be deep, accompanied by tears, and trigger a reflexive "almost orgasmic" sensation in some patients.
- •Onset typically within the first 2-4 weeks of starting the medication or after a dose increase. Often dose-dependent — higher SSRI doses produce more pronounced yawning.
- •Management: dose reduction, within-class switch, or watching to see if it attenuates over 6-8 weeks. Many patients tolerate it once they understand what's causing it.
- •For patients who find SSRI yawning intolerable or socially limiting and aren't responding well to alternatives, ketamine's different mechanism doesn't produce the symptom.
Medications most associated with this
What this is
SSRI excessive yawning is uncontrollable, repeated yawning that's disconnected from tiredness, boredom, or low oxygen. Patients describe yawning every few minutes throughout the day — in meetings, while talking, even mid-sentence. Yawns are often deep and prolonged, sometimes accompanied by watery eyes. A small subset of patients report an unusual sensation during the yawn — sometimes described as pleasurable or even orgasmic — which is itself a recognized phenomenon in the literature. The yawning is socially noticeable; patients report being asked if they're tired or bored even when they're engaged and rested.
Why it happens
The mechanism involves serotonin's action on yawning-control pathways in the hypothalamus and brainstem. Increased 5-HT activity in these centers triggers reflexive yawning independent of arousal state or oxygen levels. The phenomenon is documented across the SSRI and SNRI class — fluoxetine, sertraline, paroxetine, escitalopram, and venlafaxine have all been reported. Prevalence in case series ranges from 5-15%, though many patients don't report it because they don't connect it to the medication.
Typical timeline
Onset typically within the first 1-4 weeks of starting the SSRI or after a dose increase. Some patients see attenuation over 6-8 weeks as the brain adapts; others have persistent yawning throughout treatment. Resolution after stopping the SSRI is usually within days to a few weeks. Dose-dependence is consistent — higher doses produce more pronounced yawning, and lowering the dose often resolves it.
Management options
Discuss with your prescriber before adjusting any medication. These are options to bring up in conversation.
Watch and wait (first 8 weeks)
For mild yawning that's not socially limiting, watching over 6-8 weeks often reveals attenuation. Patients who understand the mechanism often tolerate it once they know it's not a sign of something wrong.
Dose reduction
Excessive yawning is often dose-dependent. A lower SSRI dose that maintains mood control frequently resolves the yawning. Discuss with your prescriber before adjusting.
Within-class SSRI switch
Some patients yawn excessively on one SSRI but not another. Switching from Lexapro to Zoloft, or from Zoloft to Lexapro, sometimes resolves the symptom while preserving SSRI class benefit.
Switch to bupropion (Wellbutrin)
Wellbutrin doesn't share the serotonergic mechanism that drives SSRI yawning. The most direct medication switch for patients who can tolerate moving off the SSRI class.
Add bupropion to existing SSRI
Combining SSRI + bupropion can offset some serotonergic side effects (including yawning) while maintaining the SSRI's benefit.
Mechanism switch to ketamine
For patients who want to leave the SSRI class entirely because yawning is one of several intolerable side effects, ketamine's NMDA/glutamate mechanism doesn't produce the symptom.
Where ketamine fits
Ketamine doesn't increase serotonin signaling in the brainstem yawning centers — yawning isn't a documented adverse effect of therapeutic ketamine. For patients whose SSRI yawning is socially limiting, dose-related to the mood-controlling dose, and not responding to within-class switches, the mechanism switch to ketamine resolves the symptom. Most patients don't escalate to ketamine over yawning alone — but when it's one of several SSRI side effects driving the decision, it can be part of the full picture.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
Am I yawning because I'm tired or because of my medication?
If yawning started after you began the SSRI and persists even when you're well-rested, the medication is the likely cause. SSRI yawning is unrelated to fatigue — it can happen mid-sentence, in engaging conversations, after a full night's sleep. Tiredness-related yawning is more situational.
Is SSRI yawning dangerous?
No — it's socially noticeable and sometimes embarrassing, but it isn't harmful physically. The question is quality of life. If it's disrupting work meetings or social interactions in a way that's affecting your function, that's worth addressing with your prescriber.
Why does yawning sometimes feel almost pleasurable?
This is a recognized phenomenon called "yawning-induced orgasm" or "yawn-orgasm syndrome," documented in case reports specifically in SSRI patients. It's a strange side effect of the underlying mechanism but isn't dangerous. Some patients find it more disconcerting than the yawning itself.
Will lowering my dose make the yawning stop?
Often yes — SSRI yawning is typically dose-dependent. A lower dose that maintains mood control frequently resolves it. Discuss the trade-off with your prescriber; usually a small dose reduction (10-25%) is worth trying.
Does ketamine cause yawning?
No — yawning isn't a documented adverse effect of therapeutic ketamine. The mechanism doesn't involve the serotonergic brainstem pathways that drive SSRI yawning. For patients who switch from SSRI to ketamine, the yawning typically resolves alongside other serotonergic side effects.
Don’t stop your medication on your own
Even mild side effects deserve a clinical conversation. Stopping or adjusting antidepressants without coordination with your prescriber can cause discontinuation syndrome, depression breakthrough, or both. Bring these options to your next appointment.
References
- Mohandoss AA et al. 2023, Neuropsychopharmacol Hung. Exploring the incidence and etiopathogenesis of pathological yawning as adverse effect of psychotropic drugs — confirms SSRI/SNRI yawning across class. PMID 38170730
- Sinha N et al. 2024, Cureus. Yawning as a rare side effect with increased escitalopram dose: a case report — illustrates the dose-dependent pattern documented in case literature. PMID 38962587
- Chan ACY. 2026, Cureus. Temporal patterns of adverse events associated with SSRIs — addresses the timing pattern of less-discussed SSRI side effects including yawning. PMID 41640900
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — adverse event profile does not include serotonergic side effects like yawning. PMID 23982301